Download Curriculum Vitae

Curriculum Vitae
Robert Louis Drapkin, M.D., F.A.C.P.
Board Certified
Diplomate Internal Medicine (June, 1975)
Diplomate Medical Oncology (June, 1979)
Fellow American College of Physicians (April, 1981)
Diplomate Hospice and Palliative Care (Feruary,2004)
Date of Birth:
09/22/1944
Marital Status:
Married
Home Address and Telephone:
1003 Bay Esplanade
Clearwater Beach, FL 34630
727-7444924
Office Addresses:
3280 McMullen Booth rd #200
Clearwater, FL 33761
727-2161141
7277961590 fax
400 Pinellas Street, Suite 300
Clearwater, FL 33756
727-4478100
7274422528 fax
CURRENT EMPLOYER
FLORIDA CANCER SPECIALISTS
Colleges Attended
Union College; Schenectady, New York:
September 1962 to June 1966 (BS)
Renssellaer Polytechnic Institute; Troy, New York:
July 1966 to August 1967 (MS)
Wayne State University Medical School; Detroit, Michigan:
September 1967 to June 1971 (MD)
1
Hospital and Academic Appointments
Medical Director, Stem Cell Program – Morton Plant Hospital, Clearwater, FL
1992 - 1997
Resident, Internal Medicine – University of Illinois Hospital; Chicago, Illinois
1971-1975
Chief Resident and Instructor Internal Medicine – University of Illinois; Chicago, Illinois
1974 – 1975
Medical Oncology/Hematology Fellowship, Memorial Sloan Kettering Cancer Center,
New York, New York, New York
July 1975 through July 1978
National Leukemia Association Fellow
Memorial Sloan-Kettering Cancer Center: New York, New York
July 1976 to June 1978
Attending Physician, Clinician I, Department of Medicine A
Roswell Park Memorial Institute; New York: June, 1978 to 1979
Research Assistant Professor, Department of Medicine
University of South Florida School of Medicine
September 1980 to 2000
Affiliate Physician
Moffitt Cancer Center, Tampa, Fl.
2000-present
Certification and Licensure
Licensed to practice in Florida
Florida License #ME0034925
Diplomate of Internal Medicine – June, 1975
Diplomate of Medical Oncology - June, 1979
Fellow of the American College of Physicians – April, 1981
Full Member, American Society of Blood and Marrow Transplantation – 1995
Member, Solid Tumor Panel – 1997
Biographic Appointments
Who’s Who in Frontier Science and Technology: 1984
Who’s Who in the South and Southwest
Affiliations
American Society of Clinical Oncology
American Society of Internal Medicine
Robert L. Drapkin, M.D., FACP
Curriculum vitae
2
National committees
Clinical Practice Committee
American Society of Clinical Oncology: 1985 –1987
Hospital Appointments
Chief of Department of Internal Medicine – Mease Dunedin Hospital and
Mease Countryside Hospital, Dunedin, Florida – 1988
Chairman of Investigation and New Drugs and Devices Committee
Morton Plant Hospital, Florida 1987 – 1992
Current Hospital Affiliations
Morton Plant Mease – Dunedin Hospital, Dunedin, Florida
Morton Plant Mease – Countryside Hospital, Clearwater, Florida
Morton Plant Hospital – Clearwater, Florida
Research Grants
Mease Hospital Foundation for Cancer Research: 1987 - 1988 and 1988 – 1989
Special Interests
Trustee Museum of Fine Arts – St. Petersburg, Florida-Board of Directors 1994-2010
Board of Directors Florida Museum of Photographic Art, Tampa, Fl. 2010-present
Board of Directors Graphic Studio, USF, Tampa, Fl. 2010-present
Assesions Committee – Harvard Fogg Museum – 1996 – 1999
Bone Marrow Transplant and Human Peripheral Blood Stem Cell Work
Hospice Medical Director, Suncoast Hospice, Pinellas County, Fl., 2000-2014
Body Building Competitions-First Place Championships:
2014 Southeastern Competition Men over 70 years
2008 Tampa Classic Open Men Bantam Weight
2005 Southern States Competition Men over 60 years
2004 Tampa Classic Men over 50 years
presently training for National Masters in July 2015
3
1)
1975 – 1977 Clinical responsibility under the supervision of Bayard Clarkson, MD at
Memorial Sloan-Kettering Cancer Center, New York City, New York
2)
1977 – 1978 Clinical Research on human peripheral blood stem cells with Bayard
Clarkson, MD, sponsored by National Cancer Institute at Memorial Sloan- - Kettering
Cancer Center, New York City, New York. See Publication #7.
3)
1978 – 1979 Attending physician with bone marrow transplant service responsibility –
Dept. of Medicine “A”, Roswell Park Memorial Institute with Edward Henderson, MD.
Robert L. Drapkin, M.D., FACP
Curriculum vitae
4)
1992 – present Co-Founder and Co-Director of the stem cell program at Morton Plant
Hospital
5)
Publications Numbers 5,7,16,17
6)
Member of American Society for Blood and Marrow Transplantation 1996 – present
7)
Elected Fellow American College of Physicians 1981
8)
Board Certified Internal Medicine by the American Board of Internal Medicine1975
9)
Board Certified Medical Oncology by the American Board of Internal Medicine 1979
Miscellaneous
PHARMACEUTICAL INDUSTRY EXPERIENCE:
SUPERGEN 1999-2001-IND,Protocol Design, and SPEAKER to develop the drug Nipent in Malignant
Lymphoma and CLL.
Radio Talk Show – WSUN 620 AM “The Truth About Your Healthcare”, Interviews and Call-Ins.
1996 to 1999
Publications
1.
2.
3.
4.
Drapkin, R.L., Otsuka, A.L., Castellanos, H., ElHindi, S., Niwicka, H., and Levitan, R.,:
Acquisition of a Pyloric Septum or Pyloric Duodenal Fistula. Gastroenterology 66: pp.
1234-1236, 1974.
Drapkin, R.L., Gee, T., Dowling, M., McKenzie, S., and Clarkson, B.: Prophylactic
Heparinization with Daunomycin (Dauno.) and Arabinosylcytosine (Ara-C) in Acute
Promyelocytic Leukemia (APL). Proceedings of the Nineteenth Annual Meeting of the
American Society of Hematology, Boston, Mass., December, 1976, p. 127 (#222).
Drapkin, R.L., Gee, T., Dowling, M., McKenzie, S., and Clarkson, B.: Prophylactic
Heparin Therapy in Acute Promyelocytic Leukemia. Cancer 4l: p.2484-2490, 1978
Drapkin, R.L., Gee, T.S., Arlin, Z., McKenzie, S., and Clarkson, B.: A Three Year
Evaluation of Prophylactic Heparin Therapy During Remission Induction in Acute
4
5.
6.
7.
8.
9.
Promyelocytic Leukemia in Adults. Proceedings, American Society of Clinical Oncology.
19: p. 408, 1978 (#C-405).
Drapkin, F.L., Epstein, J., Preisler, H., and Higby, D.: Characterization of Normal Human
Myeloid Progenitor Cells in Myeloblast-Promyelocyte Enriched Samples of Normal Bone
Marrow. Proceedings of American Association Cancer Research 20: p.215, 1979
Drapkin, R.L., Bjornsson, S., Higby, D., Getaz, E.P., Henderson, E.S., Caracnadas, J.,
Wallens, W.T., Kuberka, N., Suh, S., and Siddiqi, N.: Adriamycin,
Diamminedichloroplatinum and C. Parvum in Non-Small Cell Bronchogenic Carcinoma.
Proceedings American Society Clinical Oncology 20: p. 349, 1979
Drapkin, R.L., Andreeff, M., Koziner, B., Strife, A., Wisniewski, N., Darzynkiewicz, Z.,
Melamed, M.R., and Clarkson, B.: Sub-populations of Human Peripheral Blood Cells:
Analysis of Granulocytic Progenitor Cells by Flow Cytometry and Immunologic Surface
Marks. American Journal of Hematology. Pending 1979
Drapkin, R.L., Bjornsson, S., Nacher, C., Higby, D., Caracnadas, J., Wallens, W.T.,
Kuberka, N., Suh, K. Siddiqi, N., And Henderson, E.: Adriamycin,
Daimminedichloroplatinum and Corynebacterium Parvum in Non-Small Cell
Bronchogenic Carcinoma. Cancer Treatment Reports, March, 1980
Drapkin, R.L., Mayor, H., Douglas, H., and Creaven, P.: Sequential Methotrexate (MTX)
and 5-Fluorouracil (5FU) in Human Malignant Diseases, A Synergistic Regimen.
Proceedings, American Society of Clinical Oncology 21: p. 345, 1980 (#C-104)
Robert L. Drapkin, M.D., FACP
Curriculum vitae
10.
11.
12.
13.
14.
15.
16.
17.
18.
Drapkin, R.L., Paladine, W., Ayres, V., Price, L., Sokol, G., Krim, E. and Scheinbaum, M.:
Danazol, An Inhibitor of LH and FSH in the Treatment of Recurrent or Metastatic Breast
Carcinoma. Proceedings, American Society of Clinical Oncology 22: p. 447 (#447)
Drapkin RL, Griffiths E, McAloon E, Paladine W, Sokol G, Lyman G: Sequential
Methotrexate and 5-fluoracil in adenocarcinoma of the colon and rectum. Proc Am Soc
Clin Oncol 1981;22:453(#C-471).
Drapkin, R.L., McAloon, E., Sokol, G., Paladine, W., Marks, R.: The Antiemetic Effect of
Dexamethasone in Patients Receiving Cis-Platinum. Proceedings, American Society of
Clinical Oncology 22: p.419, 1981 (#C-685)
Drapkin, R.L., Stanton, G., Nealy, R., Bennett, G., Levin, H., Cavanaugh, D.: Sequential
Methotrexate, Velban and Cis-Diamminedichloroplatinum in Advanced Ovarian Cancer
Refractory to Initial Chemotherapy. Proceedings, American Society of Clinical Oncology.
3: p. 175, 1984 (#C-685)
Drapkin, R.L., Cobb, S.M., Nagelkerk, J., Leaverton, P., Osterly, S., McCreary, R., and
Stanton, G.: Anxiety Traits and States and Nausea and Vomiting in Patients Receiving
Chemotherapy. Proceedings, American Society of Clinical Oncology 5: p.243, 1986
Drapkin, R.L., Stanton, G., McCreary, R., McAloon, E., Solomon, E., Lyman, G., Osterly,
S., Spielberger, C.D.: State Anxiety, Trait Anxiety and Anger Expression in Oncology
Patients Receiving Chemotherapy. Proceedings, American Society of Clinical Oncology.
7: p. 270, 1988 (#1048)
Drapkin, R.L., Weaver, C.H., Potz, J., Redmond, J., Tauer, K., Schwartzberg, L.S.,
Kaywin, P., Grant, B., Buchner, C.D.: Engraftment and Outcomes of Patients Receiving
Myeloblative Therapy followed by Autologous Peripheral Blood Stem Cells with a Low
CD34+Cell Content. Biology of Blood and Marrow Transplantation, February, 1997
Drapkin, R.L., Weaver, C.H. Schwartzberg, L.S., Birch, R., Greco, F.A., Hainsworth, J.,
Campos, L., Grapski, R., Schwerkoske, J., Lautersztain, J., Administration of Paclitaxel,
Cyclophosphamide and Filgrastim in Patients with Breast and Ovarian Cancer. Biology
of Blood and Marrow Transplantation, February, 1997
Demetri, Kris, Wade, Degos, and Cella for the Procrit Study Group: Quality-of-Life
Benefit in Chemotherapy Patients Treated with Epoetin Alfa Is Independent of Disease
5
19.
20.
21.
22.
23.
Response or Tumor Type: Results From a Prospective Community Oncology Study.
Journal of Clinical Oncology, Vol. 16, No 10 (October), 1998, p. 3412-3425
Drapkin, R.L., Barolo, J.L.: Effect of Granisetron on Performance Status during HighDose Interferon Therapy, Oncology, International Journal of Cancer Research and
Treatment, November, 1999
Drapkin, R., Stanton, G, McCreary, R., Barolo, J.: Phase I/II Trial of Topotecan (T) and
Docetaxel (D) as Treatment for Refractory Metastatic Breast Cancer. Proceedings,
American Society of Clinical Oncology, 2000, #464, p120a
Drapkin, R.: Pentostatin and Rituximab in the Treatment of Patients With B-Cell
Malignancies. Oncology, June, 2000, Vol. 14 No.6, Supplement No.2 p. 25
Drapkin, R.L., Kalman, Leonard A., Birch, Robert, Sysel, Irene Ann, Schwartzberg, Lee
S., Peacock, Nancy, Leff, Richard, Santala, Roger, Hainsworth, John: Intensive
Induction Chemotherapy Followed by High Dose Alkylator Consolidation With Peripheral
Blood Stem Cell Rescue For Patients With Newly Diagnosed High-Grade Non-Hodgkin’s
Lymphoma. Proceedings, American Society of Clinical Oncology, 2001
Drapkin, R.L.: Pentostatin and Rituximab in Follicle Center Lymphomas and Chronic
th
Lymphocytic Leukemia, Abstract #77, Presented at the 18 Annual Mount Sinai School of
Medicine’s Chemotherapy Foundation Symposium. Nov 8-11, 2000. New York
6